What Is The Forecast Valuation Of The Global Pancreatic Cancer Diagnostic Market Projected To Reach $6.36 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Pancreatic Cancer Diagnostic Market Valuation Change Between Now And 2029?
The market size for pancreatic cancer diagnosis has been on a robust growth trajectory in recent periods. The market is projected to expand from $4.24 billion in 2024 to $4.54 billion in 2025, marking a compound annual growth rate (CAGR) of 7.0%. The significant growth during the historical period is a result of advancements in genomic and molecular profiling, progress in chemotherapy, refinement in radiation therapy, research focused on pancreatic cancer genetics, awareness initiatives, and endeavors towards early detection.
The market size for pancreatic cancer diagnostics is anticipated to witness robust growth in the approaching years, estimated to reach $6.36 billion by 2029 with a compound annual growth rate (CAGR) of 8.8%. This projected growth within the forecast period can be credited to the progress in liquid biopsy technologies, targeted therapies, the application of artificial intelligence in diagnostics, custom-tailored medicine approaches, early detection biomarkers, and the use of neoadjuvant therapies. Other significant trends for the forecast period comprise research in immunotherapy, breakthroughs in imaging technologies, innovative surgical techniques, worldwide collaborative research programs, and the incorporation of big data analytics.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11981&type=smp
What Underlying Factors Are Supporting The Pancreatic Cancer Diagnostic Market Growth?
The escalating prevalence of pancreatic cancer is projected to drive the expansion of the pancreatic cancer diagnostic market. Pancreatic cancer is characterized by the formation of malignant (cancerous) cells within the pancreatic tissues. Factors majorly contributing to the rise in pancreatic cancer include smoking, diabetes, chronic pancreatitis, a familial history of pancreatic cancer, inflammation of the pancreas, and certain genetic disorders. Diagnosis is pivotal in pancreatic cancer for driving treatment choices, determining cancer stage, recognizing the tumor’s specific traits, and customizing treatment strategies to enhance outcomes and maximize patient care. For example, in 2023, the American Society of Clinical Oncology, a professional organization based in the U.S., predicts that 64,050 individuals (33,130 men and 30,920 women) will be diagnosed with pancreatic cancer. In terms of incidence, it ranks eighth in women and tenth in men. The incidence rate of pancreatic cancer has been rising by roughly 1% per annum in both genders. Consequently, the increasing prevalence of pancreatic cancer is spurring the growth of the pancreatic cancer diagnostic market.
Which Sub-Segments Are Driving Growth Within The Pancreatic Cancer Diagnostic Market?
The pancreatic cancer diagnosticmarket covered in this report is segmented –
1) By Product: Instruments; Consumables; Services
2) By Treatment: Surgery; Chemotherapy; Radiation Therapy; Targeted Therapy
3) By Cancer Type: Exocrine; Adenocarcinoma; Squamous Cell Carcinoma; Adenosquamous Carcinoma; Colloid Carcinoma; Endocrine
4) By Test Type: Imaging Test; Biopsy; Blood Test; Genomic Test; Other Test Types
5) By End-User: Hospitals; Diagnostic Centers; Cancer Research Centers; Academic Institutes; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Instruments: Imaging Systems; Biopsy Devices; Endoscopy Equipment
2) By Consumables: Reagents; Biopsy Needles; Assay Kits
3) By Services: Diagnostic Testing Services; Laboratory Services; Consulting Services
What Future-Focused Trends Are Anticipated In The Pancreatic Cancer Diagnostic Market?
In the pancreatic cancer diagnostic market, the trend of product innovation is increasingly gaining traction. To maintain their market position, companies within this sector are embracing novel solutions. In a prominent example from March 2023, Prestige Biopharma Limited, a biopharmaceutical firm based in Singapore, introduced a pioneering diagnostic kit for the detection of PAUF, a potent tool for early pancreatic cancer detection. PAUF, or Pancreatic Adenocarcinoma Upregulated Factor, is a distinctive biomarker linked to early metastasis and is overexpressed in around 80% of pancreatic cancer situations. This groundbreaking diagnostic method showcases high precision and accuracy in pinpointing PAUF. Early research indicated that the PAUF expression level in the blood plasma of patients with pancreatic cancer is almost 1.9 times more than that in healthy individuals, as stated by Prestige Biopharma’s Innovative Discovery Center.
Which Companies Hold A Competitive Edge In The 341 Market?
Major companies operating in the pancreatic cancer diagnostic market include Pfizer Inc., Hitachi Medical Corporation, F. Hoffmann-La Roche AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Danaher Corporation, Siemens Healthcare GmbH, FUJIFILM Corporation, Becton Dickinson and Company, Koninklijke Philips N.V., GE Healthcare Bio Sciences AB, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Qiagen Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Biological Dynamics Inc., Berg LLC, Abcodia Ltd., Acobiom, Amplified Sciences LLC, Avant Diagnostics Inc., Axim Biotechnologies Inc., Alaunus Biosciences Inc., Advanced Marker Discovery SL, Anixa Diagnostics Corporation
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-report
Which Region Dominates The Pancreatic Cancer Diagnostic Market Today?
North America was the largest region in the pancreatic cancer diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pancreatic cancer diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=11981&type=smp
Browse Through More Reports Similar to the Global Pancreatic Cancer Diagnostic Market 2025, By The Business Research Company
Design Research Promotional And Consulting Services Global Market Report 2025
Architectural Engineering Consultants And Related Services Global Market Report 2025
Powder Coatings Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/powder-coatings-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
